ATE254178T1 - Expression heterologer proteine in abgeschwächten bakterien mittels des htra-promotors - Google Patents
Expression heterologer proteine in abgeschwächten bakterien mittels des htra-promotorsInfo
- Publication number
- ATE254178T1 ATE254178T1 AT95907080T AT95907080T ATE254178T1 AT E254178 T1 ATE254178 T1 AT E254178T1 AT 95907080 T AT95907080 T AT 95907080T AT 95907080 T AT95907080 T AT 95907080T AT E254178 T1 ATE254178 T1 AT E254178T1
- Authority
- AT
- Austria
- Prior art keywords
- htra
- proteins
- heterologue
- promotor
- expression
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 3
- 230000002238 attenuated effect Effects 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 101150007028 HTRA1 gene Proteins 0.000 title 1
- 102100021119 Serine protease HTRA1 Human genes 0.000 title 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 101150018266 degP gene Proteins 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 101150007310 htrA gene Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9401795A GB9401795D0 (en) | 1994-01-31 | 1994-01-31 | Vaccines |
| PCT/GB1995/000196 WO1995020665A1 (en) | 1994-01-31 | 1995-01-31 | Expression of heterologous proteins in attenuated bacteria using the htra-promoters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE254178T1 true ATE254178T1 (de) | 2003-11-15 |
Family
ID=10749598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95907080T ATE254178T1 (de) | 1994-01-31 | 1995-01-31 | Expression heterologer proteine in abgeschwächten bakterien mittels des htra-promotors |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0742829B1 (de) |
| JP (1) | JP3731004B2 (de) |
| KR (1) | KR100392916B1 (de) |
| AT (1) | ATE254178T1 (de) |
| AU (1) | AU701384B2 (de) |
| BR (1) | BR9506666A (de) |
| CA (1) | CA2182315C (de) |
| CZ (1) | CZ285867B6 (de) |
| DE (1) | DE69532109T2 (de) |
| DK (1) | DK0742829T3 (de) |
| ES (1) | ES2210283T3 (de) |
| FI (1) | FI119476B (de) |
| GB (1) | GB9401795D0 (de) |
| HU (1) | HU222982B1 (de) |
| NZ (1) | NZ278930A (de) |
| PL (1) | PL180091B1 (de) |
| PT (1) | PT742829E (de) |
| SK (1) | SK99696A3 (de) |
| WO (1) | WO1995020665A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9720033D0 (en) * | 1997-09-19 | 1997-11-19 | Medeva Plc | Hepatitis B virus polypeptides |
| US20020168771A1 (en) * | 2001-05-08 | 2002-11-14 | Gamerman Gary Eric | Vectors having replication, immunogenicity and/or pathogenicity under stress promoter regulation and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU634153B2 (en) * | 1988-02-01 | 1993-02-18 | Wyeth Holdings Corporation | T-cell epitope as carriers molecule for conjugate vaccines |
| CA2031468A1 (en) * | 1989-12-08 | 1991-06-09 | Mitchell S. Gross | Malaria vaccine |
| GB9007194D0 (en) * | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
| WO1992015689A1 (en) * | 1991-03-05 | 1992-09-17 | The Wellcome Foundation Limited | Expression of recombinant proteins in attenuated bacteria |
| ATE174628T1 (de) * | 1992-07-31 | 1999-01-15 | Medeva Holdings Bv | Expression rekombinanter fusionsproteine in attenuierten bakterien |
-
1994
- 1994-01-31 GB GB9401795A patent/GB9401795D0/en active Pending
-
1995
- 1995-01-31 WO PCT/GB1995/000196 patent/WO1995020665A1/en active IP Right Grant
- 1995-01-31 JP JP51995795A patent/JP3731004B2/ja not_active Expired - Lifetime
- 1995-01-31 BR BR9506666A patent/BR9506666A/pt not_active Application Discontinuation
- 1995-01-31 SK SK996-96A patent/SK99696A3/sk unknown
- 1995-01-31 PL PL95315670A patent/PL180091B1/pl unknown
- 1995-01-31 NZ NZ278930A patent/NZ278930A/en not_active IP Right Cessation
- 1995-01-31 CZ CZ962182A patent/CZ285867B6/cs not_active IP Right Cessation
- 1995-01-31 ES ES95907080T patent/ES2210283T3/es not_active Expired - Lifetime
- 1995-01-31 DK DK95907080T patent/DK0742829T3/da active
- 1995-01-31 AT AT95907080T patent/ATE254178T1/de active
- 1995-01-31 HU HU9602084A patent/HU222982B1/hu not_active IP Right Cessation
- 1995-01-31 CA CA002182315A patent/CA2182315C/en not_active Expired - Lifetime
- 1995-01-31 AU AU15415/95A patent/AU701384B2/en not_active Ceased
- 1995-01-31 PT PT95907080T patent/PT742829E/pt unknown
- 1995-01-31 EP EP95907080A patent/EP0742829B1/de not_active Expired - Lifetime
- 1995-01-31 DE DE69532109T patent/DE69532109T2/de not_active Expired - Lifetime
- 1995-01-31 KR KR1019960704245A patent/KR100392916B1/ko active IP Right Grant
-
1996
- 1996-07-30 FI FI963016A patent/FI119476B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3731004B2 (ja) | 2006-01-05 |
| DE69532109T2 (de) | 2004-08-26 |
| HUT75734A (en) | 1997-05-28 |
| AU1541595A (en) | 1995-08-15 |
| PT742829E (pt) | 2004-04-30 |
| SK99696A3 (en) | 1997-01-08 |
| EP0742829A1 (de) | 1996-11-20 |
| HU222982B1 (hu) | 2004-01-28 |
| WO1995020665A1 (en) | 1995-08-03 |
| HU9602084D0 (en) | 1996-09-30 |
| CA2182315C (en) | 2005-11-15 |
| AU701384B2 (en) | 1999-01-28 |
| KR970700770A (ko) | 1997-02-12 |
| KR100392916B1 (ko) | 2003-10-22 |
| GB9401795D0 (en) | 1994-03-23 |
| FI119476B (fi) | 2008-11-28 |
| BR9506666A (pt) | 1997-09-09 |
| CA2182315A1 (en) | 1995-08-03 |
| CZ218296A3 (en) | 1996-10-16 |
| FI963016A (fi) | 1996-09-25 |
| JPH09508276A (ja) | 1997-08-26 |
| CZ285867B6 (cs) | 1999-11-17 |
| DK0742829T3 (da) | 2004-03-22 |
| PL315670A1 (en) | 1996-11-25 |
| PL180091B1 (pl) | 2000-12-29 |
| ES2210283T3 (es) | 2004-07-01 |
| NZ278930A (en) | 1998-07-28 |
| FI963016A0 (fi) | 1996-07-30 |
| EP0742829B1 (de) | 2003-11-12 |
| DE69532109D1 (de) | 2003-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7235794A (en) | Vaccine compositions | |
| DE69229221T2 (de) | Expression rekombinanter proteine in attenuierten bakterien | |
| DK0618976T3 (da) | Syntetisk DNA-sekvens med forbedret insekticid virkning i majs | |
| MX9707071A (es) | Sistema de expresion de antigenos heterologos como proteinas de fusion. | |
| MY120693A (en) | Human bikunin | |
| FI863891A (fi) | Menetelmiä sekropiinin ja muiden heterologisten polypeptidien tuottamiseksi bakteeri-isännässä araB-promoottoria käyttäen sekä menetelmissä käyttökelpoisia replikoituvia ekspressiovälineitä, geneettisiä muodostelmia ja bakteereja | |
| ATE254178T1 (de) | Expression heterologer proteine in abgeschwächten bakterien mittels des htra-promotors | |
| DK0805204T3 (da) | Bitestikel - specifikt receptorprotein og anvendelse heraf | |
| DE69941099D1 (de) | Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria | |
| IL86065A0 (en) | Bacillus thuringiensis p-2 toxin gene protein and related insecticide compositions | |
| AU2001251410A1 (en) | 12303, a novel human twik molecule and uses thereof | |
| IT8521507A0 (it) | Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni. | |
| GB2295394A (en) | Vaccine Compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0742829 Country of ref document: EP |